Target Name: MAP3K6
NCBI ID: G9064
Review Report on MAP3K6 Target / Biomarker Content of Review Report on MAP3K6 Target / Biomarker
MAP3K6
Other Name(s): MAPKKK6 | MEKK6 | ASK2 | MAP3K6 variant 1 | Mitogen-activated protein kinase kinase kinase 6 | Mitogen-activated protein kinase kinase kinase 6 (isoform 1) | Apoptosis signal-regulating kinase 2 | M3K6_HUMAN | mitogen-activated protein kinase kinase kinase 6 | apoptosis signal-regulating kinase 2 | Mitogen-activated protein kinase kinase kinase 6, transcript variant 1

MAPKKK6: A Protein in Cell Signaling Pathways

MAPKKK6, also known as Pykisin-1 (PKK1), is a protein that plays a crucial role in cell signaling pathways. It is a part of the MAPKKK family, which includes several proteins involved in cell signaling, including MAPKK1 (Pykisin-2) , MAPKK2 (Pykisin-3), MAPKK3 (Pykisin-4), and MAPKK4 (Pykisin-5).

MAPKKK6 is a 21-kDa protein that is expressed in various tissues, including brain, heart, and muscle. It is involved in a wide range of cellular processes, including cell growth, differentiation, and survival. It is also involved in several signaling pathways , including the MAPKK signaling pathway.

The MAPKK signaling pathway is a complex signaling pathway that is involved in many cellular processes, including cell growth, differentiation, and survival. It is characterized by the formation of a cascade of MAPKK intermediates, which are then activated by a final kinase, MAPKK4. The MAPKK signaling pathway is activated by several different factors, including growth factors, oxygen availability, and cellular stress.

MAPKKK6 is one of the key proteins involved in the MAPKK signaling pathway. It is a key regulator of the activity of the MAPKK4 kinase, which is involved in the formation of the MAPKK intermediates. It is also involved in the regulation of the activity of the MAPKK3 kinase , which is involved in the formation of the MAPKK2 intermediates.

In addition to its role in the MAPKK signaling pathway, MAPKKK6 is also involved in several other cellular processes. It is involved in the regulation of cell adhesion, which is the process by which cells stick together to form tissues and organs. in the regulation of cell survival, as it is involved in the regulation of cell cycle progression and apoptosis.

MAPKKK6 is a protein that is potential drug target and has been identified as a biomarker for several diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. Studies have shown that MAPKKK6 is involved in the regulation of cellular processes that are implicated in the development and progression of these diseases.

In conclusion, MAPKKK6 is a protein that plays a crucial role in cell signaling pathways. It is a key regulator of the activity of the MAPKK4 kinase, which is involved in the formation of the MAPKK intermediates. It is also involved in the regulation of cell adhesion , cell survival, and the regulation of cellular processes that are implicated in the development and progression of cancer, neurodegenerative diseases, and cardiovascular diseases. As a result, MAPKKK6 is a potential drug target and a biomarker for several diseases.

Protein Name: Mitogen-activated Protein Kinase Kinase Kinase 6

Functions: Component of a protein kinase signal transduction cascade. Activates the JNK, but not ERK or p38 kinase pathways

The "MAP3K6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MAP3K6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MAP3K7 | MAP3K7CL | MAP3K8 | MAP3K9 | MAP3K9-DT | MAP4 | MAP4K1 | MAP4K1-AS1 | MAP4K2 | MAP4K3 | MAP4K3-DT | MAP4K4 | MAP4K5 | MAP6 | MAP6D1 | MAP7 | MAP7D1 | MAP7D2 | MAP7D3 | MAP9 | MAPK1 | MAPK10 | MAPK10-AS1 | MAPK11 | MAPK12 | MAPK13 | MAPK14 | MAPK15 | MAPK1IP1L | MAPK3 | MAPK4 | MAPK6 | MAPK6P2 | MAPK7 | MAPK8 | MAPK8IP1 | MAPK8IP1P2 | MAPK8IP2 | MAPK8IP3 | MAPK9 | MAPKAP1 | MAPKAPK2 | MAPKAPK3 | MAPKAPK5 | MAPKAPK5-AS1 | MAPKBP1 | MAPRE1 | MAPRE1P2 | MAPRE2 | MAPRE3 | MAPT | MAPT-AS1 | MAPT-IT1 | MARCHF1 | MARCHF10 | MARCHF11 | MARCHF11-DT | MARCHF2 | MARCHF3 | MARCHF4 | MARCHF5 | MARCHF6 | MARCHF6-DT | MARCHF7 | MARCHF8 | MARCHF9 | MARCKS | MARCKSL1 | MARCO | MARF1 | MARK1 | MARK2 | MARK2P5 | MARK2P9 | MARK3 | MARK4 | MARS1 | MARS2 | MARVELD1 | MARVELD2 | MARVELD3 | MAS1 | MAS1L | MASP1 | MASP2 | MAST1 | MAST2 | MAST3 | MAST4 | MASTL | MAT1A | MAT2A | MAT2B | MATCAP1 | MATCAP2 | MATK | MATN1 | MATN1-AS1 | MATN2 | MATN3